Abstract. We studied the actions of tolbutamide on the release of somatostatin, insulin, and glucagon from the isolated, perfused dog pancreas. Tolbutamide (180 \ g=m\ m) elicited a biphasic response of all three islet hormones in the absence of glucose. In the presence of normal glucose (5.5 mm), 180 
in the absence of glucose. At the highest perfusate glucose of 11 mM, no augmentation of the somatostatin output was seen to 180 \g=m\m tolbutamide, whereas the B and A cell secretion was still stimulated. In dose-response studies with tolbutamide (1.8\p=m-\1800 \g=m\m) it was found that the D cell threshold to tolbutamide was 18 \g=m\m,Furthermore, that maximal D cell secretion was attained in the presence of 180 \g=m\m tolbutamide at low glucose (1.4 mm) and of 18 \g=m\m tolbutamide at normal glucose (5.5 (Ipp et al. 1977; Samols et al. 1978; Efendic et al. 1979 Efendic et al. , 1980 (Iversen & Miles 1971 (Hermansen et al. 1979a,b; Hermansen 1980a Hermansen ,b, 1981 (Page 1963) , which is a non-parametric paired test designed to test for the presence of trends in data. Otherwise Stu¬ dent's i-tests were used. In all cases a 5% limit of confidence was employed to assess the significance of differences.
Results
Dynamics of tolbutamide-stimulated hormone release at zero, normal, and high glucose
The effects of 10 min infusions of tolbutamide upon D, B, and A cell secretion were studied at zero, normal (5.5 mM) and high (11 mM) glucose concentrations in five perfusion experiments (Fig. 1) (Fig. 1, left part) . When the glucose concentration was raised to 5.5 mM, the somatostatin and insulin release was augmented and glucagon was suppressed (Fig. 1, Fig. 2 . At the glucose concentration of 1.4 mM (Fig. 2, A (Fig. 2, B) . By increasing the sulphonylurea concentration above these concentra¬ tions at the respective perfusate glucoses, a prompt but transient somatostatin output was seen. The rebound after withdrawal of tolbutamide was elici¬ ted when the second phase was absent or even consisted of a slight suppression. As expected, insulin réponses to tolbutamide were biphasic. Also the A cell réponses were biphasic, however, with a relatively high, sustained second phase. Fig. 3 pg/ml (control) vs 31 ±3 pg/ml; mean ± sem, n = 3) or the release of insulin (3 ± 1 (iU/ml (con¬ trol) vs 3 ± 1 uU/ml; mean ± sem, n = 3). (Braselton et al. 1977 (Henquin 1980; Malaisse et al. 1980) . Since the present evidence points to a key regulatory role for calcium in the cascade of events that proceeds to pancreatic somatostatin (Hermansen 1979 (Hermansen , 1980a Hermansen et al. 1978 Hermansen et al. , 1979a Hermansen et al. , b, 1980 , glucagon (Hermansen & Iversen (Samols & Harrison 1977; Efendic et al. 1979 Efendic et al. , 1980 
